Stathmin expression alters the antiproliferative effect of eribulin in leiomyosarcoma cells

Stathmin expression alters the antiproliferative effect of eribulin in leiomyosarcoma cells

Uterine leiomyosarcoma is an aggressive soft tissue tumor. Stathmin, a phosphoprotein that modulates microtubule dynamics, is highly expressed in many malignancies including leiomyosarcoma. The microtubule-depolymerizing agent eribulin has been recently approved for treating malignant soft tissue tu...

Full description

Bibliographic Details
Main Authors:	Mana Azumi, Mikihiro Yoshie, Nami Nakachi, Atsuya Tsuru, Kazuya Kusama, Kazuhiro Tamura
Format:	Article
Language:	English
Published:	Elsevier 2022-12-01
Series:	Journal of Pharmacological Sciences
Subjects:	Stathmin Eribulin Microtubule Leiomyosarcoma PP2A
Online Access:	http://www.sciencedirect.com/science/article/pii/S1347861322000731

Similar Items

Stathmin dynamics modulate the activity of eribulin in breast cancer cells
by: Mikihiro Yoshie, et al.
Published: (2021-08-01)

Efficacy of Eribulin in Soft Tissue Sarcomas
by: Edward Phillips, et al.
Published: (2022-03-01)

Dermal Fibroblast Migration and Proliferation Upon Wounding or Lipopolysaccharide Exposure is Mediated by Stathmin
by: Ruiyan Cen, et al.
Published: (2022-01-01)

Therapeutic efficacy of a four-year treatment with eribulin in a patient with uterine leiomyosarcoma: A case report
by: Motoki Matsuura, et al.
Published: (2023-06-01)

Efficacy of Eribulin Plus Gemcitabine Combination in L-Sarcomas
by: María López-Álvarez, et al.
Published: (2022-12-01)

Cellular and Molecular Effects of Eribulin in Preclinical Models of Hematologic Neoplasms
by: Hugo Passos Vicari, et al.
Published: (2022-12-01)

Hypoxia destroys the microstructure of microtubules and causes dysfunction of endothelial cells via the PI3K/Stathmin1 pathway
by: Huaming Cao, et al.
Published: (2019-02-01)

Activity of Eribulin in a Primary Culture of Well-Differentiated/Dedifferentiated Adipocytic Sarcoma
by: Alessandro De Vita, et al.
Published: (2016-12-01)

Multifarious targets beyond microtubules—role of eribulin in cancer therapy
by: Priya Seshadri, et al.
Published: (2021-12-01)

Preclinical activity of selinexor in combination with eribulin in uterine leiomyosarcoma
by: Sonam Mittal, et al.
Published: (2023-09-01)

Eribulin in Cancer Treatment
by: Umang Swami, et al.
Published: (2015-08-01)

Eribulin and Paclitaxel Differentially Alter Extracellular Vesicles and Their Cargo from Triple-Negative Breast Cancer Cells
by: Petra J. Pederson, et al.
Published: (2021-06-01)

Molecular Evolution and Characterization of Fish Stathmin Genes
by: Jun Cao, et al.
Published: (2020-08-01)

Eribulin drug review
by: Nishitha Shetty, et al.
Published: (2014-01-01)

the Immunohistochemical Study of Stathmin-1 as A Prognostic factor In Non-small cell lung carcinoma
by: Nadhema Bahaa Hussein Wetwet, et al.
Published: (2023-01-01)

Effect of Albendazole on Tau and Stathmin Expression in Metastatic Breast Cancer
by: Sepideh Javdan, et al.
Published: (2024-01-01)

Advances in the treatment of soft tissue sarcoma: focus on eribulin
by: Koliou P, et al.
Published: (2018-02-01)

PARP Inhibition Sensitizes Breast Cancer Cells to Eribulin
by: Bahram Sharif-Askari, et al.
Published: (2023-03-01)

Dexmedetomidine protects PC12 cells from lidocaine-induced cytotoxicity via downregulation of Stathmin 1
by: Tan Y, et al.
Published: (2019-07-01)

Effects of Eribulin on the RNA Content of Extracellular Vesicles Released by Metastatic Breast Cancer Cells
by: Matteo Giulietti, et al.
Published: (2024-03-01)

Eribulin and Confusion: A Previously Unknown Drug Side-Effect
by: Abu Baker Sheikh, et al.
Published: (2020-06-01)

The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models
by: Leila Takahashi-Ruiz, et al.
Published: (2022-12-01)

Stathmin mediates TNF-α-induced skin fibroblast migration by promoting formation of filopodia
by: CEN Ruiyan, et al.
Published: (2022-04-01)

Efficacy and safety of eribulin in HER2-negative metastatic breast cancer: the results of long-term experience in real clinical practice in Russia
by: Vera A Gorbunova, et al.
Published: (2019-03-01)

Stathmins and Motor Neuron Diseases: Pathophysiology and Therapeutic Targets
by: Delia Gagliardi, et al.
Published: (2022-03-01)

Stathmin-2 Mediates Glucagon Secretion From Pancreatic α-Cells
by: Farzad Asadi, et al.
Published: (2020-02-01)

Eribulin for the treatment of anthracyclineand taxane-resistant breast cancer: a big step forward towards problem solving
by: E V Artamonova
Published: (2017-09-01)

Small GTP‐binding protein Rap1 mediates EGF and HB‐EGF signaling and modulates EGF receptor expression in HTR‐8/SVneo extravillous trophoblast cells
by: Mikihiro Yoshie, et al.
Published: (2023-01-01)

Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective study
by: Sakura Iizumi, et al.
Published: (2017-12-01)

Eribulin alongwith capecitabine in relapsed carcinoma breast- a retrospective single-Institutional study.
by: Soumita Poddar, et al.
Published: (2023-08-01)

Simvastatin Downregulates Cofilin and Stathmin to Inhibit Skeletal Muscle Cells Migration
by: Li-Ping Lin, et al.
Published: (2022-03-01)

The results of the first retrospective data analysis of eribulin application in patients with metastatic breast cancer in actual clinical practice in Russia
by: L V Bolotina, et al.
Published: (2016-09-01)

Prognostic Role of High Stathmin 1 Expression in Patients with Solid Tumors: Evidence from a Meta-Analysis
by: Qingyan Mao, et al.
Published: (2018-10-01)

Relationship between Expression of β-tubulin-Ⅲ Plus Stathmin in Advanced Non-Small Cell Lung Cancer and its Sensitivity to Venorelbine Chemotherapy
by: Xiaolin PU, et al.
Published: (2009-01-01)

The relationship between the expression of Stathmin and tumor immune cell infiltration in primary cervical carcinoma and its prognostic diagnostic value
by: Hui Yang, et al.
Published: (2023-12-01)

Eribulin Efficacy on Brain Metastases in Heavily Pretreated Patients with Metastatic Breast Cancer
by: Renaud Sabatier, et al.
Published: (2021-03-01)

The effect of downregulation of Stathmin gene on biological behaviors of U373 and U87-MG glioblastoma cells
by: Ping Liu, et al.
Published: (2018-06-01)

The efficacy of the combination of eribulin and trastuzumab in advanced HER2-positive breast cancer: the results of Russian observational study
by: Elena I. Kovalenko, et al.
Published: (2020-05-01)

Standardized Cannabis sativa extract attenuates tau and stathmin gene expression in the melanoma cell line
by: Golnaz Vaseghi, et al.
Published: (2017-10-01)

Indolyl-chalcone derivatives trigger apoptosis in cisplatin-resistant mesothelioma cells through aberrant tubulin polymerization and deregulation of microtubule-associated proteins
by: Sophia Steinlein, et al.
Published: (2023-05-01)